Oxcarbazepine 60 MG/ML Oral Suspension — RxCUI 283536
RxNorm drug concept · Semantic clinical drug
RxCUI 283536
Semantic clinical drug · SCD
● Current RxNorm concept 22 FDA products
28 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI283536
Official nameOxcarbazepine 60 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asoxacarbazepine 300 MG per 5 ML Oral Suspension; oxacarbazepine 300 MG in 5 mL Oral Suspension
FDA products mapped22
Package NDCs mapped28
Reported Medicaid activity (SDUD)231,726 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Oxcarbazepine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats partial-onset seizures, which start in one area of the brain. Depending on the product and your age, it may be used alone or along with other seizure medicines. Your phar...
- Take it by mouth exactly as prescribed. Immediate-release tablets and the suspension are usually taken twice a day, with or without food. Extended-release products like Oxtellar XR...
- Dizziness, sleepiness, tiredness, double vision, nausea, headache, and unsteadiness are the most common. Be careful driving until you know how it affects you. Tell your doctor if t...
- Call for any new rash, blistering, or peeling skin, or swelling of the face, lips, or throat. Also call for confusion, severe headache or nausea, more seizures, or mood changes and...
🕸️ Concept Web — How Oxcarbazepine 60 MG/ML Oral Suspension Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Oxcarbazepine 60 MG/ML Oral Suspension
RxCUI 283536 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Oxcarbazepine
32624IN
-
Oxcarbazepine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Trileptal
261680BN
-
Trileptal
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Oxcarbazepine Oral Suspension
375197SCDF -
Oxcarbazepine Oral Liquid Product
1160128SCDG -
Oxcarbazepine Oral Product
1160129SCDG -
Oxcarbazepine Oral Suspension [Trileptal]
365857SBDF -
Trileptal Oral Liquid Product
1183778SBDG -
Trileptal Oral Product
1183779SBDG -
Oral Suspension
316969DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Oxcarbazepine Oral Suspension
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Oxcarbazepine 60 MG/ML
332278SCDC -
Oxcarbazepine 60 MG/ML Oral Suspension [Trileptal]
351992SBD -
Oxcarbazepine 60 MG/ML [Trileptal]
575736SBDC
-
Oxcarbazepine 60 MG/ML
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Oxcarbazepine 60 MG/ML
SCDC · 332278 -
Oxcarbazepine Oral Suspension
SCDF · 375197 -
Oxcarbazepine Oral Liquid Product
SCDG · 1160128 -
Oxcarbazepine Oral Product
SCDG · 1160129
Brand-Name Concepts
-
Oxcarbazepine 60 MG/ML Oral Suspension [Trileptal]
SBD · 351992 -
Oxcarbazepine 60 MG/ML [Trileptal]
SBDC · 575736 -
Oxcarbazepine Oral Suspension [Trileptal]
SBDF · 365857 -
Trileptal Oral Liquid Product
SBDG · 1183778 -
Trileptal Oral Product
SBDG · 1183779 -
Trileptal
BN · 261680
📦 FDA Products & Package NDCs
22 products · 28 package NDCs
28 package NDCs map to RxCUI 283536 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00078-0337-05 | 100 TABLET, FILM COATED in 1 BOTTLE (0078-0337-05) | Trileptal | Novartis Pharmaceuticals Corporation | 2000-01-30 |
| 00078-0337-06 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (0078-0337-06) / 1 TAB... | Trileptal | Novartis Pharmaceuticals Corporation | 2000-01-30 |
| 00078-0357-52 | 250 mL in 1 BOTTLE (0078-0357-52) | Trileptal | Novartis Pharmaceuticals Corporation | 2001-05-30 |
| 00078-0456-05 | 100 TABLET, FILM COATED in 1 BOTTLE (0078-0456-05) | Trileptal | Novartis Pharmaceuticals Corporation | 2000-01-30 |
| 00078-0456-35 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (0078-0456-35) / 1 TAB... | Trileptal | Novartis Pharmaceuticals Corporation | 2000-01-30 |
| 00078-0457-05 | 100 TABLET, FILM COATED in 1 BOTTLE (0078-0457-05) | Trileptal | Novartis Pharmaceuticals Corporation | 2000-01-30 |
| 00078-0457-35 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (0078-0457-35) / 1 TAB... | Trileptal | Novartis Pharmaceuticals Corporation | 2000-01-30 |
| 10135-0798-41 | 250 mL in 1 BOTTLE, GLASS (10135-798-41) | Oxcarbazepine | Marlex Pharmaceuticals, Inc | 2025-05-01 |
| 31722-0687-25 | 1 BOTTLE in 1 CARTON (31722-687-25) / 250 mL in 1 BOTTLE | OXCARBAZEPINE | Camber Pharmaceuticals, Inc. | 2023-10-20 |
| 33342-0259-67 | 1 BOTTLE in 1 CARTON (33342-259-67) / 250 mL in 1 BOTTLE | oxcarbazepine | Macleods Pharmaceuticals Limited | 2025-07-11 |
| 42806-0600-22 | 1 BOTTLE in 1 CARTON (42806-600-22) / 250 mL in 1 BOTTLE | Oxcarbazepine | EPIC PHARMA, LLC | 2023-01-30 |
| 51672-1393-01 | 1 BOTTLE, GLASS in 1 CARTON (51672-1393-1) / 250 mL in 1 BO... | OXCARBAZEPINE | Sun Pharmaceutical Industries, Inc. | 2025-08-06 |
| 62135-0841-24 | 20 CUP, UNIT-DOSE in 1 CARTON (62135-841-24) / 5 mL in 1 CU... | Oxcarbazepine | Chartwell RX, LLC | 2024-03-27 |
| 62135-0841-54 | 250 mL in 1 BOTTLE (62135-841-54) | Oxcarbazepine | Chartwell RX, LLC | 2024-03-27 |
| 65162-0649-48 | 10 CUP, UNIT-DOSE in 1 TRAY (65162-649-48) / 5 mL in 1 CUP,... | Oxcarbazepine | Amneal Pharmaceuticals LLC | 2012-06-04 |
| 65162-0649-78 | 1 BOTTLE in 1 CARTON (65162-649-78) / 250 mL in 1 BOTTLE | Oxcarbazepine | Amneal Pharmaceuticals LLC | 2012-06-04 |
| 67877-0532-58 | 250 mL in 1 BOTTLE (67877-532-58) | Oxcarbazepine | Ascend Laboratories, LLC | 2020-01-01 |
| 68094-0123-62 | 3 TRAY in 1 CASE (68094-123-62) / 10 CUP, UNIT-DOSE in 1 TR... | Oxcarbazepine | Precision Dose, Inc. | 2017-09-13 |
| 68999-0841-24 | 2 TRAY in 1 BOX (68999-841-24) / 10 CUP in 1 TRAY / 5 mL in... | Oxcarbazepine | Chartwell Governmental & Specialty RX, LLC. | 2025-12-19 |
| 69452-0125-50 | 1 BOTTLE, GLASS in 1 CARTON (69452-125-50) / 250 mL in 1 BO... | Oxcarbazepine | Bionpharma Inc. | 2023-02-14 |
| 69452-0125-51 | 1 BOTTLE, PLASTIC in 1 CARTON (69452-125-51) / 250 mL in 1... | Oxcarbazepine | Bionpharma Inc. | 2025-12-01 |
| 70377-0117-11 | 1 BOTTLE in 1 CARTON (70377-117-11) / 250 mL in 1 BOTTLE | OXCARBAZEPINE | Biocon Pharma Inc. | 2024-05-31 |
| 72162-2088-02 | 1 BOTTLE in 1 CARTON (72162-2088-2) / 250 mL in 1 BOTTLE | Oxcarbazepine | Bryant Ranch Prepack | 2012-06-04 |
| 72162-2631-02 | 250 mL in 1 BOTTLE, GLASS (72162-2631-2) | Oxcarbazepine | Bryant Ranch Prepack | 2026-04-23 |
| 72205-0354-85 | 1 BOTTLE in 1 CARTON (72205-354-85) / 250 mL in 1 BOTTLE | OXCARBAZEPINE | Novadoz Pharmaceuticals LLC | 2026-05-29 |
| 72603-0252-01 | 1 BOTTLE in 1 CARTON (72603-252-01) / 250 mL in 1 BOTTLE | OXCARBAZEPINE | NorthStar RxLLC | 2024-05-01 |
| 72888-0074-14 | 1 BOTTLE in 1 CARTON (72888-074-14) / 250 mL in 1 BOTTLE | OXCARBAZEPINE | Advagen Pharma Ltd | 2024-02-14 |
| 85742-0007-06 | 250 mL in 1 BOTTLE, GLASS (85742-007-06) | Oxcarbazepine | Kanchan Healthcare Inc | 2025-05-01 |
Observed labelers:
Novartis Pharmaceuticals Corporation (7) ·
Amneal Pharmaceuticals LLC (2) ·
Bionpharma Inc. (2) ·
Bryant Ranch Prepack (2) ·
Chartwell RX, LLC (2) ·
Advagen Pharma Ltd (1)
· +12 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.